| Profile | GDS1873 / 216442_x_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 431.137 | 73 |
| GSM40788 | control - Rep 2 | 171.418 | 49 |
| GSM40789 | control - Rep 3 | 192.299 | 52 |
| GSM40775 | androgen treated - Rep 1 | 154.556 | 45 |
| GSM40776 | androgen treated - Rep 2 | 344.92 | 69 |
| GSM40777 | androgen treated - Rep 3 | 208.968 | 55 |
| GSM40790 | estrogen treated - Rep 1 | 212.407 | 56 |
| GSM40791 | estrogen treated - Rep 2 | 201.193 | 54 |
| GSM40792 | estrogen treated - Rep 3 | 373.307 | 70 |
| GSM40784 | A + tamoxifen - Rep 1 | 134.213 | 41 |
| GSM40785 | A + tamoxifen - Rep 2 | 138.476 | 41 |
| GSM40786 | A + tamoxifen - Rep 3 | 140.692 | 42 |
| GSM40778 | A + anastrozole - Rep 1 | 122.074 | 36 |
| GSM40779 | A + anastrozole - Rep 2 | 229.29 | 57 |
| GSM40780 | A + anastrozole - Rep 3 | 411.482 | 73 |
| GSM40781 | A + letrozole - Rep 1 | 128.407 | 37 |
| GSM40782 | A + letrozole - Rep 2 | 300.897 | 65 |
| GSM40783 | A + letrozole - Rep 3 | 975.462 | 88 |